293 related articles for article (PubMed ID: 10861424)
1. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma.
Goetze JP; Nielsen FC; Burcharth F; Rehfeld JF
Cancer; 2000 Jun; 88(11):2487-94. PubMed ID: 10861424
[TBL] [Abstract][Full Text] [Related]
2. Characterization of gastrins and their receptor in solid human gastric adenocarcinomas.
Goetze JP; Eiland S; Svendsen LB; Vainer B; Hannibal J; Rehfeld JF
Scand J Gastroenterol; 2013 Jun; 48(6):688-95. PubMed ID: 23544442
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
Monstein HJ; Ohlsson B; Axelson J
Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
[TBL] [Abstract][Full Text] [Related]
4. Expression and processing of gastrin in pancreatic adenocarcinoma.
Caplin M; Savage K; Khan K; Brett B; Rode J; Varro A; Dhillon A
Br J Surg; 2000 Aug; 87(8):1035-40. PubMed ID: 10931047
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.
Weinberg DS; Ruggeri B; Barber MT; Biswas S; Miknyocki S; Waldman SA
J Clin Invest; 1997 Aug; 100(3):597-603. PubMed ID: 9239407
[TBL] [Abstract][Full Text] [Related]
6. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
Singh P; Owlia A; Espeijo R; Dai B
J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
9. Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin.
Rehfeld JF; Bardram L; Hilsted L
Cancer Res; 1989 Jun; 49(11):2840-3. PubMed ID: 2720643
[TBL] [Abstract][Full Text] [Related]
10. The biology of cholecystokinin and gastrin peptides.
Rehfeld JF; Friis-Hansen L; Goetze JP; Hansen TV
Curr Top Med Chem; 2007; 7(12):1154-65. PubMed ID: 17584137
[TBL] [Abstract][Full Text] [Related]
11. Unexpected high incidence of cholecystokinin-B/gastrin receptors in human medullary thyroid carcinomas.
Reubi JC; Waser B
Int J Cancer; 1996 Sep; 67(5):644-7. PubMed ID: 8782652
[TBL] [Abstract][Full Text] [Related]
12. CCK-B/gastrin receptors in human colorectal cancer.
Schmitz F; Otte JM; Stechele HU; Reimann B; Banasiewicz T; Fölsch UR; Schmidt WE; Herzig KH
Eur J Clin Invest; 2001 Sep; 31(9):812-20. PubMed ID: 11589724
[TBL] [Abstract][Full Text] [Related]
13. Human cholecystokinin-A receptor is not an oncofetal protein.
Weinberg DS; So C; Ruggeri B; Biswas S; Barber M; Waldman S
Dig Dis Sci; 2000 Mar; 45(3):538-43. PubMed ID: 10749330
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas.
Saillan-Barreau C; Dufresne M; Clerc P; Sanchez D; Corominola H; Moriscot C; Guy-Crotte O; Escrieut C; Vaysse N; Gomis R; Tarasova N; Fourmy D
Diabetes; 1999 Oct; 48(10):2015-21. PubMed ID: 10512367
[TBL] [Abstract][Full Text] [Related]
15. Presence of CCK-A, B receptors and effect of gastrin and cholecystokinin on growth of pancreatobiliary cancer cell lines.
Jang JY; Kim SW; Ku JL; Park YH; Park JG
World J Gastroenterol; 2005 Feb; 11(6):803-9. PubMed ID: 15682471
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study.
Monstein HJ; Nylander AG; Salehi A; Chen D; Lundquist I; Håkanson R
Scand J Gastroenterol; 1996 Apr; 31(4):383-90. PubMed ID: 8726308
[TBL] [Abstract][Full Text] [Related]
17. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor TAS2R14: trophoblast expression and signaling.
Taher S; Borja Y; Cabanela L; Costers VJ; Carson-Marino M; Bailes JC; Dhar B; Beckworth MT; Rabaglino MB; Post Uiterweer ED; Conrad KP
Am J Physiol Regul Integr Comp Physiol; 2019 May; 316(5):R628-R639. PubMed ID: 30892908
[TBL] [Abstract][Full Text] [Related]
20. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]